Bailey David R 4
4 · ORTHOPEDIATRICS CORP · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
Orthopediatrics (KIDS) CEO David R. Bailey Sells 19,535 Shares
What Happened
- David R. Bailey, President, CEO and a director of Orthopediatrics Corp (ticker: KIDS), sold 19,535 shares on 2026-03-16 at $17.25 per share, generating proceeds of about $336,979. The sale was an open-market or private sale reported on a Form 4 filed 2026-03-17.
- This was a sale to satisfy tax withholding obligations related to the vesting of restricted shares, not an independent purchase (sales like this are typically routine for tax withholding).
Key Details
- Transaction date: 2026-03-16; filing date: 2026-03-17 (filed the next business day — appears timely).
- Price and amount: 19,535 shares at $17.25 per share; proceeds ≈ $336,979.
- Reason: Footnote F1 states shares were sold to satisfy tax withholding upon vesting of restricted shares.
- Holdings note: Footnote F2 indicates the reported holdings include restricted stock awards totaling 187,891 shares. The total post-transaction beneficial ownership amount is not specified in the provided summary.
- Transaction code: S = Sale; F = tax withholding (per footnote).
Context
- This sale was a tax-withholding sale tied to restricted stock vesting, a common administrative transaction that does not necessarily indicate a view on the company’s prospects. For retail investors, purchases are usually more informative about insider sentiment than routine withholding sales.
Insider Transaction Report
Form 4
Bailey David R
DirectorPresident and CEO
Transactions
- Sale
Common Stock
[F1][F2]2026-03-16$17.25/sh−19,535$336,979→ 298,020 total
Footnotes (2)
- [F1]Shares sold to satisfy tax withholding obligations upon vesting of restricted shares.
- [F2]Includes restricted stock awards totaling 187,891 shares.
Signature
/s/ Daniel J. Gerritzen, Attorney-in-Fact|2026-03-17